熊本大学のノウハウを活かした新たなカタチの大学院教育

英語
日本
セミナー・シンポジウム及び募集
Seminar & Symposium/Admissions
2025-05-14

最先端研究セミナー

 

講演者:荻 朋男(名古屋大学 環境医学研究所 教授)

演題:Molecular Biology and Human Genomics of Genome Instability Syndromes

 

日時:2025年5月14日(水) 12:00-13:00

開催場所:発生医学研究所1階 カンファレンス室

※ZOOMミーティングのURLはMoodleの「S-HIGO最先端研究セミナーA、B」にてご確認ください。

https://md.kumamoto-u.ac.jp/course/view.php?id=120331

 

Abstract:

Genome instability syndromes arise from deficiencies in DNA repair and DNA damage response pathways. Increasing evidence suggests that disruptions in transcription and DNA damage response mechanisms play a crucial role in the pathogenesis of rare diseases, particularly neurological disorders.

Our previous research has demonstrated that impaired transcription-coupled nucleotide excision repair (TC-NER) directly contributes to neurodegeneration, as seen in Cockayne syndrome. We also identified that digenic mutations in aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 5 (ADH5) impair the detoxification of endogenous formaldehyde, a reactive aldehyde known to cause DNA damage, leading to a novel multisystem disorder known as AMeD syndrome, characterized by neurological symptoms such as developmental delay and intellectual disability.

In parallel, through national genome initiatives such as the Initiative on Rare and Undiagnosed Diseases (IRUD) and the Japan Leading Project for Rare Disease Whole-Genome Sequencing (RDWGS), we have established one of Japan’s most advanced multi-omics analysis environments. With the installation of two Revio sequencing platforms, we launched a dedicated long-read sequencing analysis center. Utilizing long-read whole-genome sequencing and long-read RNA sequencing (ISO-Seq), we are uncovering novel insights into genomic structural variants associated with various neurological diseases.

Additionally, for ultra-rare conditions, we are actively engaged in the N-of-1 program not only for diagnosis but also for drug discovery. By integrating genomic, transcriptomic, and proteomic data, we are investigating the potential of antisense oligonucleotides (ASOs) as a therapeutic modality.

In this lecture, I will present our recent basic research findings, along with the latest advances in rare disease research enabled by long-read sequencing technologies.

 

 

担当分野:ゲノム神経学 塩田(6633)